It is thus not surprising that mutations in PARK2 and PARK6 have broad impacts on diverse physiological processes known or suspected to be affected in PD, including innate immunity, inflammation and metabolism (Figure 2). The gene discussed is PRKN; the disease is Parkinson disease.